Fazel Shokri

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, |Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

[ 1 ] - Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody

نویسندگان همکار

Forough Golsaz-Shirazi 1

Mahmood Jeddi-Tehrani 1

Mohammad Mehdi Amiri 1

Reza Hosseini-Ghatar 1

Tahereh Soltantoyeh 1